ROCK HILL, South Carolina, June 22, 2015 – 3D Systems (NYSE:DDD) announced today that it will feature its versatile personal and professional 3D printers as well as its extensive digital design tools at the Design Engineering & Manufacturing Expo (DMS) in Tokyo, Japan, June 24 – 26, 2015. Located in the Tokyo Big Site Convention Center, booth E 2-36, 3DS will showcase its workflow-enhancing 3D digital thread, which allows clients in industries such as manufacturing, healthcare and architecture to move seamlessly between scanning, designing and 3D printing to compress design windows and shorten supply chains.

Together with its partners and resellers, 3D Systems will display the ProX™ 200 Direct Metal Printer (DMP), which creates fully functional, end-use metal parts. In addition, visitors to the booth can see vibrant full-color printing on the ProJet® x60 series and ProJet® 4500 as well as multi-material composite printing on the ProJet® 5500X. Desktop printing and prototyping will also be on exhibit with the ProJet® 1200 micro-SLA 3D printer and the user-friendly Cube® and CubePro®.

During the Expo, experts from the company will showcase success stories made possible by 3DS products, including a real-life user case study on how to utilize 3D printing for injection molding as well as the latest applications in Direct Metal Printing. In addition, 3DS customers will demonstrate a range of use cases for 3D printing in the fields of medicine, architecture and education.

Learn more about 3DS' commitment to manufacturing the future today at www.3dsystems.com.

About 3D Systems 3D Systems provides the most advanced and comprehensive 3D digital design and fabrication solutions available today, including 3D printers, print materials and cloud-sourced custom parts. Its powerful ecosystem transforms entire industries by empowering professionals and consumers everywhere to bring their ideas to life using its vast material selection, including plastics, metals, ceramics and edibles. 3DS' leading personalized medicine capabilities save lives and include end-to-end simulation, training and planning, and printing of surgical instruments and devices for personalized surgery and patient specific medical and dental devices. Its democratized 3D digital design, fabrication and inspection products provide seamless interoperability and incorporate the latest immersive computing technologies. 3DS' products and services disrupt traditional methods, deliver improved results and empower its customers to manufacture the future now.

Leadership Through Innovation and Technology

3DS invented 3D printing with its Stereolithography (SLA) printer and was the first to commercialize it in 1989.

3DS invented Selective Laser Sintering (SLS) printing and was the first to commercialize it in 1992.

3DS invented the ColorJet Printing (CJP) class of 3D printers and was the first to commercialize 3D powder-based systems in 1994.

3DS invented MultiJet Printing (MJP) printers and was the first to commercialize it in 1996.

3DS Medical Modeling pioneered virtual surgical planning (VSP) and its services are world-leading, helping many thousands of patients on an annual basis.

Today its comprehensive range of 3D printers is the industry's benchmark for production-grade manufacturing in aerospace, automotive, patient specific medical device and a variety of consumer, electronic and fashion accessories.

Forward-Looking StatementsCertain statements made in this release that are not statements of historical or current facts, including statements regarding the expected benefits and synergies of the transaction, future opportunities for the combined company and products, future financial performance and any other statements regarding 3DS' and Cimatron's future expectations, beliefs, plans, objectives, financial conditions, assumptions or future events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often use words such as "anticipate", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "hope", "aim", "continue", "will", "may", "would", "could" or "should" or other words of similar meaning or the negative thereof. These statements are subject to numerous risks and uncertainties, many of which are beyond the companies' control, which could cause actual results to differ materially from the results expressed or implied by the statements. These risks and uncertainties include, but are not limited to: the ultimate timing, outcome and results of integrating the operations of Cimatron; the effects of the business combination of 3DS and Cimatron, including the combined company's future financial condition, results of operations, strategy and plans; expected synergies and other benefits from the proposed transaction and the ability of 3DS to realize such synergies and other benefits; results of litigation, settlements, and investigations; the availability and alternative uses of 3DS' cash; actions by third parties, including governmental agencies; protection of intellectual property rights and against cyber attacks; compliance with environmental laws; changes in government regulations and regulatory requirements; risks of international operations, including risks relating to unsettled political conditions, war, the effects of terrorism, and foreign exchange rates and controls, international trade and regulatory controls. The factors described under the headings "Forward-Looking Statements," "Cautionary Statements and Risk Factors," and "Risk Factors" in 3DS' report on Form 10-K for the year ended December 31, 2013 and Cimatron's report on Form 20-F for the year ended December 31, 2013, and other U.S. Securities and Exchange Commission (the "SEC") filings of 3DS and Cimatron discuss some of the important risk factors identified that may affect these factors and 3DS' and Cimatron's respective business, results of operations and financial condition. 3DS and Cimatron undertake no obligation to revise or update publicly any forward-looking statements for any reason. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.